$MEDE
Medies

2023 Q3 Form 10-Q Financial Statement

#000168316823007133 Filed on October 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 2022 Q3
Revenue $0.00 $1.840K $1.598K
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $1.840K $1.598K
YoY Change -100.0%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $12.62K $63.16K
YoY Change 9768.75%
% of Gross Profit 3432.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.947K $18.77K $1.947K
YoY Change 0.0% 4165.91%
% of Gross Profit 1020.11% 121.84%
Operating Expenses $12.62K $63.16K $7.237K
YoY Change 74.4% 9768.75%
Operating Profit -$12.62K -$61.32K -$5.639K
YoY Change 123.82% 9481.25%
Interest Expense $172.00 $700.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$172.00 $694.00 $48.00
YoY Change -458.33%
Pretax Income -$12.79K -$60.63K -$5.591K
YoY Change 128.81% 9373.44%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.79K -$60.63K -$5.591K
YoY Change 128.81% 9373.44%
Net Earnings / Revenue -3295.11% -349.87%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 6.667M shares 4.941M shares 4.034M shares
Diluted Shares Outstanding 6.667M shares 4.941M shares 4.034M shares

Balance Sheet

Concept 2023 Q3 2023 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $430.00 $1.860K
YoY Change 365.0%
Cash & Equivalents $426.00 $1.860K $14.59K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $426.00 $1.860K $14.59K
YoY Change -97.08% 365.0%
LONG-TERM ASSETS
Property, Plant & Equipment $26.83K $30.73K $34.62K
YoY Change -22.5% -20.2%
Goodwill
YoY Change
Intangibles $21.65K $34.71K
YoY Change -37.62%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $48.48K $58.91K $69.33K
YoY Change -30.07% -9.61%
TOTAL ASSETS
Total Short-Term Assets $426.00 $1.860K $14.59K
Total Long-Term Assets $48.48K $58.91K $69.33K
Total Assets $48.91K $60.77K $83.92K
YoY Change -41.72% -7.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.820K $1.000K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $58.92K $55.47K
YoY Change 37.61%
Total Short-Term Liabilities $63.74K $56.47K $49.50K
YoY Change 28.77% 40.09%
LONG-TERM LIABILITIES
Long-Term Debt $12.50K $12.50K
YoY Change
Other Long-Term Liabilities $25.50K $25.50K
YoY Change 0.0%
Total Long-Term Liabilities $38.00K $38.00K $38.00K
YoY Change 0.0% 49.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.74K $56.47K $49.50K
Total Long-Term Liabilities $38.00K $38.00K $38.00K
Total Liabilities $101.7K $94.47K $87.50K
YoY Change 16.28% 43.55%
SHAREHOLDERS EQUITY
Retained Earnings -$80.39K -$16.17K
YoY Change 397.2%
Common Stock $667.00 $520.00
YoY Change 28.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$52.83K -$33.70K -$3.578K
YoY Change
Total Liabilities & Shareholders Equity $48.91K $60.77K $83.92K
YoY Change -41.72% -7.32%

Cashflow Statement

Concept 2023 Q3 2023 2022 Q3
OPERATING ACTIVITIES
Net Income -$12.79K -$60.63K -$5.591K
YoY Change 128.81% 9373.44%
Depreciation, Depletion And Amortization $1.947K $18.77K $1.947K
YoY Change 0.0% 4165.91%
Cash From Operating Activities -$3.880K -$40.86K
YoY Change 20330.0%
INVESTING ACTIVITIES
Capital Expenditures $12.50K
YoY Change -80.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$12.50K
YoY Change -80.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.450K 54.82K
YoY Change -17.2%
NET CHANGE
Cash From Operating Activities -3.880K -40.86K
Cash From Investing Activities -12.50K
Cash From Financing Activities 3.450K 54.82K
Net Change In Cash -430.0 1.460K
YoY Change 265.0%
FREE CASH FLOW
Cash From Operating Activities -$3.880K -$40.86K
Capital Expenditures $12.50K
Free Cash Flow -$53.36K
YoY Change -18.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Central Index Key
EntityCentralIndexKey
0001918694
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-264308
dei Entity Registrant Name
EntityRegistrantName
MEDIES
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1651594
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Geng Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94303
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
719-5286
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
MEDE
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6666500 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
426 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1862 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
426 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1862 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21653 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28183 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26831 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30725 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
48484 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
58908 usd
CY2023Q3 us-gaap Assets
Assets
48910 usd
CY2023Q1 us-gaap Assets
Assets
60770 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4820 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1001 usd
CY2023Q3 MEDE Loans From Related Parties
LoansFromRelatedParties
58917 usd
CY2023Q1 MEDE Loans From Related Parties
LoansFromRelatedParties
55467 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63737 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
56468 usd
CY2023Q3 MEDE Note Payable Related Party
NotePayableRelatedParty
12500 usd
CY2023Q1 MEDE Note Payable Related Party
NotePayableRelatedParty
12500 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
101737 usd
CY2023Q1 us-gaap Liabilities
Liabilities
94468 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
667 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
667 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26899 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26899 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80393 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61264 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-52827 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-33698 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48910 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60770 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
1598 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
1598 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1598 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
1598 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
7255 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
7950 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5366 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7237 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10835 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17176 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
12621 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7237 usd
us-gaap Operating Expenses
OperatingExpenses
18785 usd
us-gaap Operating Expenses
OperatingExpenses
17176 usd
CY2023Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2022Q3 us-gaap Other Operating Income
OtherOperatingIncome
48 usd
us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Other Operating Income
OtherOperatingIncome
48 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
172 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
344 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-172 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-344 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12793 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5591 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19129 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15530 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-12793 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5591 usd
us-gaap Net Income Loss
NetIncomeLoss
-19129 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6666500 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6666500 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4034456 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4034456 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6666500 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6666500 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4017228 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4017228 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-33698 usd
us-gaap Net Income Loss
NetIncomeLoss
-19129 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-52827 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-239 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12191 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3578 usd
us-gaap Net Income Loss
NetIncomeLoss
-19129 usd
us-gaap Net Income Loss
NetIncomeLoss
-15530 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
6530 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4446 usd
us-gaap Depreciation
Depreciation
3894 usd
us-gaap Depreciation
Depreciation
3894 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3819 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4886 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7190 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12191 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3450 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
9185 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3450 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33876 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1436 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14186 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1862 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
426 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14586 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80393 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_z66o7UbgLQGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates and Assumptions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38930 usd
CY2023Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2023Q3 us-gaap Depreciation
Depreciation
1947 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1947 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12099 usd
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3265 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2223 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17527 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4017 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
12655 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4017 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12655 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4017 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12655 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4017 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12655 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
80393 usd

Files In Submission

Name View Source Status
mede-20230831_lab.xml Edgar Link unprocessable
0001683168-23-007133-index-headers.html Edgar Link pending
0001683168-23-007133-index.html Edgar Link pending
0001683168-23-007133.txt Edgar Link pending
0001683168-23-007133-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
mede-20230831.xsd Edgar Link pending
mede-20230831_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mede-20230831_def.xml Edgar Link unprocessable
medies_ex3101.htm Edgar Link pending
medies_ex3102.htm Edgar Link pending
medies_ex3201.htm Edgar Link pending
medies_ex3202.htm Edgar Link pending
medies_i10q-083123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mede-20230831_pre.xml Edgar Link unprocessable
medies_i10q-083123_htm.xml Edgar Link completed